E for L Aim Public Company Limited (EFORL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, E for L Aim Public Company Limited (EFORL) has a cash flow conversion efficiency ratio of -0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿-7.25 Million ≈ $-226.13K USD) by net assets (฿583.26 Million ≈ $18.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See E for L Aim Public Company Limited (EFORL) defensive interval to measure how many days the company can operate on defensive assets alone.
E for L Aim Public Company Limited - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how E for L Aim Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
E for L Aim Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of E for L Aim Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TG Metals Ltd
AU:TG6
|
-0.028x |
|
BELLINI NAUTICA S.P.A.
F:F2F
|
N/A |
|
Diagnos Inc
V:ADK
|
0.539x |
|
Sun&L Co Ltd
KO:002820
|
-0.006x |
|
Modernland Realty Ltd Tbk
JK:MDLN
|
0.000x |
|
TFP Solutions Bhd
KLSE:0145
|
-0.142x |
|
PT Cahayasakti Investindo Sukses Tbk
JK:CSIS
|
0.018x |
|
NexturnBioscience Co. Ltd
KQ:089140
|
0.019x |
Annual Cash Flow Conversion Efficiency for E for L Aim Public Company Limited (2007–2025)
The table below shows the annual cash flow conversion efficiency of E for L Aim Public Company Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see EFORL company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ฿583.26 Million ≈ $18.18 Million |
฿114.42 Million ≈ $3.57 Million |
0.196x | -35.24% |
| 2024-12-31 | ฿544.31 Million ≈ $16.97 Million |
฿164.90 Million ≈ $5.14 Million |
0.303x | +304.17% |
| 2023-12-31 | ฿524.62 Million ≈ $16.35 Million |
฿39.32 Million ≈ $1.23 Million |
0.075x | -83.02% |
| 2022-12-31 | ฿506.42 Million ≈ $15.78 Million |
฿223.60 Million ≈ $6.97 Million |
0.442x | +427.48% |
| 2021-12-31 | ฿392.89 Million ≈ $12.25 Million |
฿-52.97 Million ≈ $-1.65 Million |
-0.135x | +68.32% |
| 2020-12-31 | ฿-741.64 Million ≈ $-23.12 Million |
฿315.66 Million ≈ $9.84 Million |
-0.426x | -27.25% |
| 2019-12-31 | ฿-104.57 Million ≈ $-3.26 Million |
฿34.98 Million ≈ $1.09 Million |
-0.334x | +27.80% |
| 2018-12-31 | ฿276.72 Million ≈ $8.63 Million |
฿-128.19 Million ≈ $-4.00 Million |
-0.463x | +89.17% |
| 2017-12-31 | ฿-95.56 Million ≈ $-2.98 Million |
฿408.69 Million ≈ $12.74 Million |
-4.277x | -1654.17% |
| 2016-12-31 | ฿1.99 Billion ≈ $61.97 Million |
฿-484.70 Million ≈ $-15.11 Million |
-0.244x | -1075.22% |
| 2015-12-31 | ฿3.00 Billion ≈ $93.45 Million |
฿74.95 Million ≈ $2.34 Million |
0.025x | +139.75% |
| 2014-12-31 | ฿1.95 Billion ≈ $60.76 Million |
฿-122.60 Million ≈ $-3.82 Million |
-0.063x | -17940.51% |
| 2013-12-31 | ฿697.78 Million ≈ $21.75 Million |
฿246.00K ≈ $7.67K |
0.000x | -99.99% |
| 2012-12-31 | ฿31.32 Million ≈ $976.19K |
฿74.19 Million ≈ $2.31 Million |
2.369x | +3050.37% |
| 2011-12-31 | ฿96.75 Million ≈ $3.02 Million |
฿7.28 Million ≈ $226.76K |
0.075x | -42.49% |
| 2010-12-31 | ฿148.70 Million ≈ $4.63 Million |
฿19.44 Million ≈ $606.05K |
0.131x | +25.67% |
| 2009-12-31 | ฿273.21 Million ≈ $8.52 Million |
฿28.43 Million ≈ $886.02K |
0.104x | -52.62% |
| 2008-12-31 | ฿265.97 Million ≈ $8.29 Million |
฿58.40 Million ≈ $1.82 Million |
0.220x | -32.01% |
| 2007-12-31 | ฿166.53 Million ≈ $5.19 Million |
฿53.78 Million ≈ $1.68 Million |
0.323x | -- |
About E for L Aim Public Company Limited
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia. The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, … Read more